News
Cancer Vanishes For All Patients ‘First Time In History’ During Drug Trial
“There were a lot of happy tears.”
A new drug has left doctors astonished after all their 18 participants were considered in remission one year after its trial. Dostarlimab is the name of the drug, and it’s described as laboratory-produced molecules that act as substitute antibodies in the human body. The drug tested for colorectal cancer returned a 100% success rate in clinical trials.
To confirm its effectiveness, doctors conducted physical exams, endoscopies, PET scans, and MRI scans and could not find any trace of cancer in their participants’ bodies. Dr. Luis A. Diaz Jr. of New York’s Memorial Sloan Kettering Cancer Center has said it was the first time this had happened in the history of cancer.
Dr. Alan P. Venook, a colorectal cancer specialist at the University of California, wasn’t involved with the study, but he has since applauded the research as a world-first.
Notably, Dr. Diaz and his team have published a paper on their findings in the New England Journal of Medicine, where they described their phenomenal results. Now, the findings are making waves in the medical world, with Dr. Venook telling the New York Times that complete remission in every single patient is unheard of.
He pointed out it was impressive as none of the patients suffered significant complications from the trial drug.
The eighteen rectal cancer patients had gotten involved in grueling treatments, including chemotherapy, radiation, and invasive surgery that could result in the bowel, urinary, and even s*xual dysfunction. The patients went into the trial expecting to go through the next step, but instead, no further treatment was needed. Memorial Sloan Kettering Cancer Center and co-author of the paper, oncologist Dr. Andrea Cercek has since also described the moment patients found they were cancer-free.
She reportedly said: “There were a lot of happy tears.”
However, colorectal cancer, known as bowel cancer, affects 100,000 Australians years, according to Cancer Australia. Back in May, a team of US doctors unveiled their groundbreaking research that could mean we are well on our way to a cure. They injected the first-ever human patient with Vaxina, which was proven successful in animal testing for the cancer-killing virus. So far, the Oncolytic virus has been found to shrink colon, lung, breast, ovarian, and pancreatic cancer tumors in animal trials.
